Zhejiang Shouxiangu Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the breeding, cultivation, processing, and sale of Chinese medicinal he...
Tmall Health has joined dozens of brands to establish the "Health Supplement Assurance Alliance"
Shouxiangu released its performance for the first three quarters, with a net profit attributable to the parent company of 76.34 million yuan, a year-on-year decrease of 33.47%
Shouxiangu: Subsidiary "Shouxiangu Brand Ganoderma Spore Oil Soft Capsules" product completes re-registration as a domestic health food
Shouxiangu: 2025 Shareholder Return Program Launch
Shouxiangu: Net profit of 65.5586 million yuan in the first half of 2025, a year-on-year decrease of 33.99%
Shouxiangu: Two products have completed the domestic health food filing